Table 1.
Clinical characteristics of ovarian cancer patients.
| Characteristic | Low expression of MSLN | High expression of MSLN | p |
|---|---|---|---|
| N | 189 | 190 | |
| Tumor status, n (%) | 0.006 | ||
| Tumor free | 47 (13.9%) | 25 (7.4%) | |
| With tumor | 122 (36.2%) | 143 (42.4%) | |
| OS event, n (%) | 0.010 | ||
| Alive | 86 (22.7%) | 61 (16.1%) | |
| Dead | 103 (27.2%) | 129 (34%) | |
| DSS event, n (%) | 0.004 | ||
| Alive | 91 (25.7%) | 63 (17.8%) | |
| Dead | 86 (24.3%) | 114 (32.2%) | |
| Lymphatic invasion, n (%) | 0.351 | ||
| No | 27 (18.1%) | 21 (14.1%) | |
| Yes | 47 (31.5%) | 54 (36.2%) | |
| Race, n (%) | 0.482 | ||
| Asian | 8 (2.2%) | 4 (1.1%) | |
| Black or African American | 12 (3.3%) | 13 (3.6%) | |
| White | 161 (44.1%) | 167 (45.8%) | |
| Age, n (%) | 0.199 | ||
| <=60 | 97 (25.6%) | 111 (29.3%) | |
| >60 | 92 (24.3%) | 79 (20.8%) | |
| Venous invasion, n (%) | 1.000 | ||
| No | 23 (21.9%) | 18 (17.1%) | |
| Yes | 35 (33.3%) | 29 (27.6%) | |
| Age, median (IQR) | 60 (50, 70) | 58 (52, 66) | 0.950 |